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KIT REGULATORY ELEMENTS REQUIRED FOR EXPRESSION IN 
DEVELOPING HEMATOPOIETIC AND GERM CELL LINEAGES.
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Abstract
The Kit (White) gene encodes the transmembrane receptor of Stem Cell Factor / Kit Ligand 
(KL), and is essential for the normal development/maintenance of pluripotent Primordial Germ 
Cells (PGC), Hematopoietic Stem Cells (HSC), melanoblasts and some of their descendants. The 
molecular basis for the trancriptional regulation of Kit during development of these important cell 
types is unknown. We investigated Kit regulation in hematopoietic cells and PGCs. We identified 
six DNase I hypersensitive sites (HS1-HS6) within the promoter and first intron of the mouse Kit 
gene and developed mouse lines expressing transgenic Green Fluorescent Protein (GFP) under the 
control of these regulatory elements. A construct driven by the Kit promoter and including all six 
HS sites is highly expressed during mouse development in Kit
+ cells including PGCs and 
hematopoietic progenitors (BFU-E and CFU - Mix). In contrast, the Kit promoter alone (comprising 
HS1) is sufficient to drive low level GFP expression in PGCs, but unable to function in 
hematopoietic cells. Hematopoietic expression further requires the addition of the intron-proximal 
HS2 fragment; HS2 also greatly potentiates the activity in PGCs. Thus HS2 acts as an enhancer 
integrating transcriptional signals common to two developmentally unrelated stem cell/progenitor 
lineages. Optimal hematopoietic expression further requires HS3-HS6.
Corresponding Author’s e-mail: sergio.ottolenghi@unimib.it
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Introduction
Stem cells are traditionally considered to be either multipotent (e.g. Embryonic Stem -ES- cells) or 
restricted in their differentiation potential (tissue stem cells). Reports on “transdifferentiation” and 
the discovery of multipotent adult progenitor cells in bone marrow, brain and muscle, have recently 
challenged this view 
1-5. One central issue underlying the debate on developmental options of stem 
cells  concerns  the  molecular  mechanisms  responsible  for  establishing  and  maintaining  their 
transcriptional programs and decisions to differentiate. So far,  few of the key regulatory  genes 
active in stem cells and/or multipotent progenitors have been studied at the level of transcriptional 
regulation 
6-17. Identification and comparison of several such genes will provide important insights 
into the transcriptional programs of stem and multipotent progenitor cells.
The Kit (White spotting locus) gene, encoding the transmembrane receptor of the cytokine Stem 
Cell Factor/ Kit Ligand (KL), is an important regulator of proliferation/survival and/or migration of 
several stem cell types such as the primordial germ cells (PGC) 
18-22, the multipotent hematopoietic 
stem cells (HSC)
20,23, the neural crest and the intestinal Cajal cells 
20. Null mutations in the Kit or 
the KL (Steel) gene result in severe hematopoietic and germ cell defects and in utero or perinatal 
death, whereas mutations that diminish Kit tyrosine kinase activity or KL production affect mainly 
hematopoiesis  and  the  development  of  germ  cells,  melanocytes  and  the  intestinal  Cajal  cells
20. 
During mouse development Kit is expressed at low level in pluripotent inner cell mass cells (and in 
epiblast-derived  -ES-  cells  in  culture) 
24,25  and,  at  relatively  higher  levels,  in  PGCs,  early 
hematopoietic progenitors and other cells 
25. In adults, Kit is expressed in a variety of cell types 
including HSCs, immature hematopoietic progenitors and mast cells, oocytes, a subpopulation of 
male germ cells and melanocytes 
18-23,25.
In the mouse embryo, hematopoietic progenitors are detected both extraembryonically in the 
yolk sac, after Embryonic day 7 (E7) and intraembryonically, first in the paraaortic splanchnopleura 
and  aorta-gonad-mesonephros  (AGM)  regions,  then  in  fetal  liver  and  vitelline  vessels 
26 - 28  and 
finally  in  bone  marrow.  The  earlier  hematopoietic  cells  (primitive  hematopoietic  cells)  are 
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morphologically  and  biologically  distinct  from  the  later  cells  (definitive  hematopoietic  cells). 
Definitive hematopoiesis is seeded by HSCs, which arise intraembryonically in the AGM and in the 
vitelline vessels around E11 
28-30. Immature precursors to definitive HSC, however, have also been 
detected both intraembryonically 
31,32 and in the yolk sac 
32 at earlier stages of development. Murine 
PGCs first become visible around E7 in the extraembryonic mesoderm, then migrate through the 
allantois (E8) to the hindgut, from where they move to reach the gonadal ridges (E9.5 to E11.5) 
22,33,34
An  important  characteristic  of  Kit  is  that  its  expression  is  common  to,  and  critical  for, 
various unrelated multipotent stem/progenitor cells, belonging to different lineages. To identify the 
Kit DNA  regulatory  element(s)  responsible  for  this  common  expression,  we  studied  the 
transcriptional regulation of Kit in early hematopoietic and germ cells. Fusing the promoter and 
enhancer elements from the first intron of the mouse Kit gene to a GFP-reporter gene, we obtained a 
construct  that  correctly  recapitulates  Kit  expression  throughout  the  development  of  both  these 
lineages. Our results highlight the essential role of a DNA region, centered on a single DNaseI 
hypersensitive site, for gene expression in two stem/multipotent lineages, PGCs and hematopoietic 
cells. 
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Materials and Methods
DNase I Hypersensitivity studies. 
Nuclei were prepared from exponentially growing cells according to Forrester et al.
35. Aliquots 
were incubated for 5 min at 37°C either without or with DNaseI (Boehringer) over a range of 0.2-10 
µg/ml.  Genomic  DNA  was  isolated  and  digested  with  appropriate  enzymes,  and  analysed  by 
Southern blotting. Kit positive cells were KL dependent SV40T-immortalized hematopoietic cells 
from bone marrow and yolk sac 
36,37, mel-c melanocytes 
38 and CCE ES cells.
Kit-GFP constructs. 
Mouse  Kit  genomic  fragments  were  cloned  from  a  ￿  Fix  II  genomic  library  (Stratagene).  An 
enhanced green fluorescent protein (EGFP) gene carrying at its 5’ an HA epitope followed by a 
nuclear localisation signal and, at its 3’, stop codons and a poly A addition site, was used as a 
reporter. The coding sequence of the EGFP gene was fused, at its initial ATG, to the first ATG of 
the first exon (and 6.7 kb 5’ flanking sequence) of the Kit gene. Fusion was obtained through a 
linker inserted at the SacI site of the Kit first exon and including 26 nucleotides from the Sac I site 
itself to the first ATG of the first Kit exon, appropriately modified to generate a NcoI site. The 
EGFP gene, cut by NcoI at its initial ATG, was ligated into the linker NcoI site, thus generating an 
in-frame Kit-EGFP fusion. This is construct 1. Construct 2 was obtained by adding, downstream to 
the EGFP polyA-addition site, the 3’ part of the first Kit exon downstream to Sac I, and ￿ 3.5 kb of 
the first intron. Construct 3 further included a 4.5 kb XbaI-BamHI fragment of the first intron. All 
constructs are flanked by SalI sites.
Transgenic mice.
Stable transgenic lines of BDF1 mice were obtained by injecting plasmid–free fragments generated 
by Sal I digestion, according to standard techniques 
39. The number of integrated constructs varied 
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between 2 and 20, as evaluated by Southern blot comparison of the intensities of hybridisation to 
GFP reporter gene, between transgenic DNA and appropriate dilutions of the constructs.
Cell isolation. 
Cells were obtained from E9.5 AGM and E8.5–10.5 yolk sac by mechanical disaggregation. The 
morning when the vaginal plug was detected was taken as E0.5. PGCs were purified from AGM of 
E10.5 embryos using the Mini-MACS method 
40, and from E11.5 gonadal ridges by the EDTA-stab 
method  
41.
Immunohistochemistry. 
Cells  were  fixed  using  freshly  prepared  4%  paraformaldehyde  in  PBS  for  10  min  at  room 
temperature. Prior to fixation, cells from gonadal ridges were attached onto a poly-l-lysine coated 
coverslip.  Alkaline  phosphatase  (AP)  staining  was  performed  as  described  in  ref. 
41. 
Immunostaining  was  performed  by  incubating  the  cells  with  solutions  containing  the  primary 
antibody in PBS with 1% BSA for 1 h at room temperature. Primary antibodies included mouse 
IgM TG-1 (kindly provided by Dr P. Donovan), biotin conjugated rat anti Kit antibody (Becton 
Dickinson) and anti HA epitope mouse monoclonal IgG 2a (Santa Cruz). Secondary antibodies 
were  anti-mouse-IgM-TRITC  (Sigma)  for  TG-1,  streptavidin  PE  (Sigma)  for  anti  Kit  and  anti-
mouse  IgG  FITC  (Sigma)  for  HA.  Incubation  was  30  min  at  room  temperature.  For  cryostat 
sections, E9.5 embryos were fixed in 4% paraformaldehyde for 15 min at 4°C, washed in PBS, 
immersed in OCT embedding matrix (Cell Path) and frozen in liquid nitrogen vapour. Serial 7µ
sections were stained for AP activity and with anti-HA and TG-1 antibodies.
Fluorescence-activated cell-sorting (FACS) analysis. 
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Fetal liver cells from transgenic mice were obtained by disaggregation in PBS, stained with anti Kit 
(45 min 4°C), washed and incubated with streptavidin PE (45min 4°C) and analysed with a Becton 
Dickinson FACS scan for both GFP and Kit fluorescence.
Sorting of GFP 
+ cells and colony assays.
Fetal liver cells were sorted into a GFP
+(> 5 x 10
1 fluorescence units) and a GFP
-
 population (< 2 x 
10
1 fluorescence units), using FACS Vantage; adult bone marrow cells were sorted into a GFP
-
population, and two GFP
+ populations of intermediate and high fluorescence, respectively. Cells 
were cultured in IMDM containing ￿-thioglycerol, methylcellulose, BSA, 5% FCS, iron-saturated 
transferrin, lecithin, oleic acid, cholesterol, 2 U/ml human recombinant erythropoietin, 10 ng/ml 
murine KL, 10 ng/ml murine IL-3. Small erythroid colonies from CFU-E were counted after 2 days 
of culture, and larger erythroid, mixed and granulocyte/macrophage colonies were scored on days 
7-14 
42.
Results
DNase I hypersensitive sites in Kit chromatin. 
The mouse Kit gene is over 80 kb-long, and includes at least 21 exons; the first two exons are 
separated by a large (￿ 20 kb) intron 
43. Inherited Kit expression defects due to distant upstream 
deletions suggested the existence of long-range-acting regulatory sequences 
44,45. To additionally 
identify proximal regulatory elements we cloned ￿ 10 kb of 5’ flanking sequences and the whole 
first exon and intron, and explored DNase I sensitivity of this DNA region in chromatin from Kit 
expressing hematopoietic, melanocytic and ES cells as well as non-expressing hematopoietic cells. 
Digestion with EcoRI and hybridization with probe A (Fig.1A, B) causes the appearance of two 
bands (HS1, HS2) with DNA from Kit
+ cells, ES and melanocytes, and an additional band (HS3-
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HS6) with DNA from Kit
+ hematopoietic cells. No bands are seen in Kit
-
 cells (lymphoid A20, Fig. 
1A and other lines, not shown). Further experiments with other enzymes and probes B and C (Fig. 
1C) show that HS1 maps in the promoter within approximately 300 nt upstream to the cap site, HS2 
just downstream (500-700 nt) to the first exon, whereas the hematopoietic-specific HS3-6 band 
splits into four different downstream sites (HS3 to HS6) (Fig.1C).
Fig. 1. DNase I hypersensitivity of Kit 5’-flanking, exon I and first intron region in chromatin 
from Kit expressing and non expressing cells. (A) DNA from DNaseI treated nuclei was digested 
with EcoRI and hybridised to probe A (see B). HS sites are indicated. (B) Restriction map of the 
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region analyzed. (C) Fine mapping of HS3-6. Probes and restriction enzymes used are indicated. 
Molecular weight markers correspond to bands  obtained by double digestion with EcoRI/XbaI, 
EcoRI/HindIII,  EcoRI/SacI,  of  plasmids  containing  the  cloned  EcoRI  fragment  (A),  run  and 
hybridised  in  parallel  to  the  genomic  DNA.  Similarly  (C),  double  digestions  were  XbaI/BglI, 
XbaI/BglII,  XbaI/HindIII  for  plasmids  containing  the  cloned  XbaI  fragment;  BamHI/BglII, 
BamHI/PstI (BamHI fragment); BamHI/PstI, BamHI/XbaI BamHI/HindIII (BamHI/BglI fragment).
The  nucleotide  sequence  of  the  first  exon/first  intron  of  the  kit  gene  is  reported  in  GenBank 
(NT_039306). Nucleotide1 of the first intron corresponds to nt. 559 of this sequence; the positions 
of the Hind III (near HS2), Bgl II (near HS3,4) and Xba I (near HS5,6) sites correspond to nt. 1071, 
4941 and 7047 of the first intron, respectively. 
Expression of transgenic constructs in the hematopoietic system and in the germ cell line. 
To evaluate the role of these sites in Kit regulation we cloned the promoter in front of a nuclear 
EGFP gene, carrying a HA epitope (construct 1) and further added a fragment comprising HS2 
(construct  2)  or  HS2-HS6  (construct  3)  (Fig.  2).  All  three  constructs  are  similarly  active  in 
transfected undifferentiated ES cells (not shown). To investigate expression during development, 
we generated several transgenic mouse lines (eight with construct 1, five with construct 2 and six 
with construct 3, Table 1). The number of integrated constructs ranged between two and twenty for 
construct 1, three and fifteen for construct 2, and two and twelve for construct 3.
For personal use only. on November 6, 2014.  by guest    www.bloodjournal.org From 10
Fig. 2. Schematic representation of constructs 1, 2, 3. EGFP not to scale. The indicated ATG 
corresponds to the first ATG of the Kit gene, and is fused in frame (at Nco I site) to the open 
reading frame of the EGFP construct. Exon 1 (black box) is split by the Sac I cut.
As  shown  in  Table  1,  all  three  constructs  are  active  in  the  developing  germ  line  (although 
construct  1  is  weaker  than  constructs  2  and  3),  whereas  only  constructs  2  and  3  are  active  in 
hematopoietic cells. Other types of expressing cells (melanocytes, neural crest, cranial ganglia etc.) 
were  not  studied  in  detail.  Ectopic  expression  was  rarely  seen  with  constructs  2  and  3;  with 
construct 1 it was seen more often, particularly as strong localized spots in the central nervous 
system. The level of expression was not related to the copy number of integrated construct. 
Table 1. Expression of Kit-GFP in transgenic mice. Frequency of mouse 
lines expressing in various sites
#.
Construct
Expression sites 1 2 3
Allantoid E8.0-8.5 1/4 2/2 3/3
AGM E9.5 3/6 5/5 6/6
Gonadal ridge/Gonad E10.5-12 3/6 4/4 6/6
Yolk Sac E9.5-12 0/7 5/5 6/6
Fetal Liver E10.5-12 0/8 1/4 5/6
Bone marrow 0/6 1/5 6/6
Ectopic 5/8 1/5 1/5
# Not all lines were examined in all sites. Other sites, possibly representing physiological 
expression, were peripheral nerve ganglia, epidermis (melanocytes?) and heart.
The  construct  3  line  described  in  detail  in  this  work  was  line  6  (two  integrated  DNA 
copies). Construct 3 line 5 (eight construct copies) gave very similar results. All other lines 
had approximately 1% (line 4, twenty copies), 2% (line 3, nine copies) and 10-15% (lines 1 
and 2, eight-ten copies) positive cells in the bone marrow. Values in fetal liver ranged 
between 0-2% (lines 4 and 3 respectively), 5-15% (lines 1 and 2) and 50-65% (lines 5 and 
6). Results in gonads, AGM and yolk sac are qualitatively similar to those presented for line 
6, although some lines (3 and 4) gave weaker fluorescence. For construct 2, line 5 (twelve 
construct copies) is described. Other examined lines were negative in fetal liver and bone 
marrow, but all lines (five-twenty construct copies) were significantly fluorescent in the 
other regions examined. The construct 1 lines gave clear, but weak, fluorescence in gonads 
and  AGM  (line  4,  five  copies-  see  Fig.  6,  and  line  2,  eight  copies).  Line  4  also  gave 
expression in allantoid. Ectopic expression was mainly in CNS, after E11.5; it was detected 
in the five expressing construct 1 lines, in construct 2 line 4 and in construct 3, line 4.
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We  characterized  in  detail  the  expression  pattern  during  development  using  one  construct  3 
mouse line (carrying 2 copies of the construct), one construct 2 line (12 copies) and two construct 1 
lines (5 and 8 copies). The data obtained with constructs 2 and 3 are essentially superimposable, 
with only minor specific differences.
GFP-expressing cells in the AGM region.
Using constructs 2 and 3, GFP
+ cells apparently migrating from the allantois into the embryo are 
initially detected at E8-8.5 (Fig. 3 AA’). Later (E9.5-10), a fluorescent streak becomes visible in the 
dorsal posterior part of the embryo, corresponding to the gut and/or aorta (Fig. 3B), where PGCs 
and hematopoietic progenitors, respectively, are located.
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Fig. 3. GFP expression of construct 3 in the allantoid, aorta and gonadal ridges regions. (AA’)
E8 allantoid, an arrowhead in A’ points to a group of fluorescent cells in the allantoid. (B) E9.5 
Embryo, (CC’ and DD’) E9.5 dissected aortas with some adjacent mesenchyme. (EE’) lateral view 
of an embryo (E10.5) truncated below and above the AGM region . One of the fluorescent gonadal 
ridges is out of focus. (FF’F’’) Cross section of E9.5 aorta and magnification of a detail; note the 
large fluorescent cell in F’’, arrowed in F’. (GG’) Cross section of the aorta. G: AP positive cells in 
the ventral part are indicated by arrows. G’: GFP ( anti HA) staining of the same region of the 
adjacent section. 
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ao:aorta; al: allantoid; gr: gonadal ridge; hg: hindgut. Note that non transgenic control embryos (and 
dissected organs) were completely non–fluorescent, even with exposure times of 90 sec (versus 8-
15 sec as used here).
To better understand the location of the fluorescent cells, we dissected the dorsal aorta, with some 
adjacent tissue. At E9.5 most fluorescent cells  are located in  close proximity to the aorta  and, 
occasionally, within it (Fig. 3 CC’, DD’ ). Later (E10.5) very few fluorescent cells reside in the 
aorta  region,  and  most  of  the  fluorescent  cells  form  two  streams  ventrally  and  laterally  to  it, 
(corresponding to the gonadal ridges, which are seen in a lateral view of a truncated embryo) (Fig. 3 
EE’).
To further investigate the nature of the fluorescent cells in the aorta region, we made transverse 
sections of the embryo. At E9.5, most of the fluorescent cells are seen as clusters located ventrally 
to the aorta (3GG’), which correspond to groups of cells positively stained for alkaline phosphatase 
activity (panel GG’) or for TG1 antibody (not shown). Thus, these cells are mostly or exclusively 
PGCs. However, some rare fluorescent cells are also present inside the aorta (Fig. 3F F’F’’) (and 
within vessels in general, not shown), occasionally adjacent to the endothelium, and may represent 
circulating hematopoietic progenitors (and/or endothelial cells).
At further later stages, fluorescent PGCs progressively accumulate in the gonadal ridges (Fig. 
4A) and then in the developing gonads, with a clearly demarcated border with the mesonephroi 
(Fig.4 BB’, CC’). Fluorescence is most intense at E12.5 and persists up to E14-14.5.
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Fig. 4. GFP expression of construct 3 in the gonads. (A) E11.5 dissected AGM. Only the gonadal 
ridges  are  fluorescent.  (BB’  and  CC’)  E13.5  female  and  male  gonads  with  the  adjacent 
mesonephroi.  Note  the  absence  of  staining  of  the  mesonephroi.  Note  that  qualitatively  similar 
results are obtained with constructs 1 and 2.
g: gonad; m: mesonephros.
Overall, with constructs 2 and 3 the pattern of GFP expression within the AGM region is largely 
superimposable  to  that  expected  for  PGCs,  a  comparatively  smaller  number  of  putative 
hematopoietic cells can also be detected. Notably, in contrast to the results obtained with constructs 
2 and 3, GFP expression with construct 1 is weak in the gonadal ridges (E10.5-11.5, see below) and 
very low, hardly detectable in the aorta region at E9.5 (not shown). 
GFP expression in hematopoietic sites. 
With constructs 2 and 3, fluorescent cells are visible extraembryonically in the yolk sac starting at 
E8-8.5 through E11.5-12, and in vitelline vessels (Fig. 5). In the yolk sac (Fig. 5AA’-DD’), many
positive cells are spread in the mesenchyme, but often tend to cluster within or along small vessels. 
In vitelline vessels (Fig. 5EE’), cells are within the wall or in the blood stream. In the fetal liver, 
fluorescence appears between E10-10.5 persisting up to E12.5-13 (see below). Postnatally, the bone 
marrow is strongly fluorescent (not shown). Importantly, no expression is detected with construct 1 
in these sites (Table 1).
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Fig. 5. GFP expression of construct 3 in yolk sac and vitelline vessels (E11.5). (AA’- DD’) Yolk 
sac; (EE’) Vitelline vessels. Note that qualitatively similar results are obtained with construct 2 (for 
example see C), but no expression is seen with construct 1, and no non-specific fluorescence is 
detected with non-transgenic embryos.
Correlation  of  GFP-fluorescence  with  Kit  expression.  PGCs  and  early  hematopoietic 
progenitors are mostly Kit
+. To evaluate if the Kit transgene is expressed within the proper cells, we 
correlated Kit membrane expression (or AP and TG1 immunostaining, which identify PGCs) with 
GFP fluorescence.
PGCs purified from the AGM (E10.5) by immunomagnetic cell sorting using TG1 antibody 
40
(Fig. 6AA’) or from the gonadal ridges (E11.5) (Fig. 6 BB’) of transgenic mice (constructs 2 and 3), 
are  mostly  GFP
+  (compare  the  alkaline  phosphatase  or  TG-1  staining  -red-  with  GFP  -green-
fluorescence), (see also Table 2). Similarly, PGCs from mice transgenic for construct 1, although 
much less fluorescent than those obtained with constructs 3 (Fig 6C,DD’,EE’) and 2 (not shown), 
are  mostly  (greater  than  80%)  GFP
+  as  well.  The  TG-1
-
  somatic  cell  fractions  from  all  three 
transgenic lines are negative (not shown).
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Fig. 6. GFP positive PGCs in the gonadal ridge. (AA’) GFP (green) and AP (red) staining in TG1 
immunopurified  gonadal  ridge  PGCs  (E10.5).  (BB’)  GFP  (green)  and  TG1  (red,  membrane 
staining) of PGCs from E11.5 gonads; in B’’ the images are merged. (C-DD’-EE’) Comparison of 
GFP  fluorescence  of  gonadal  ridge  from  construct  3  and  1  lines  (left  and  right  in  C)  and  of 
dissociated cells (D and E respectively) at E11.5. Results with construct 2 are essentially identical 
to those with construct 3. All the construct 1 lines show very weak fluorescence. No non-specific 
fluorescence is detected with non-transgenic embryos.
Yolk sac and AGM region from E8.5 and E9.5 embryos of transgenic construct 2-3 mice were 
dissected, disaggregated as single cell suspension, stained with anti-Kit antibodies and analysed by 
fluorescence microscopy. 
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Fig. 7. GFP expression in Kit positive fetal liver and yolk sac cells. (AB) FACS analysis of GFP 
and Kit fluorescence in fetal liver cells at E11.5. (AA’) construct 3; (BB’) construct 2. (AB), second 
antibody; (A’B’), first and second antibodies. (CC’’) GFP (green) and Kit (red) fluorescence in 
E9.5 yolk sac cells. No expression is seen with construct 1
The results show that a large proportion of the Kit
+ cells (from both regions) are also GFP
+ (Fig. 
7CC’ and Table 2). 
Table 2. GFP
+ cells among various progenitors cell types 
Cell type GFP
+cells(%)
Yolk sac (E8.5) Kit
+ 30-70
AGM (E9.5) Kit
+ 50-60
PGC (E10.5) Kit
+ 90-95
PGC (E11.5) Kit
+ 90-95
Fetal liver (E11-12) Kit
+ 25-85
Bone marrow (adult) Kit
+ 65-80
Fetal liver CFU-mix 57*   16**
BFU-E  57*  37**
CFU-GM 52*   6**
CFU-E  n.a.*  64**
* E11;** E12-12.5. Average of two experiments.
n.a. not acquired. Data for construct 3 transgenics
For personal use only. on November 6, 2014.  by guest    www.bloodjournal.org From 18
In fetal liver cells, obtained from E11.5 embryos, about 80% of Kit
+ cells are also highly GFP
+, 
as  shown  by  FACS  analysis  (Fig.  7AA’  constructs  2  and  3);  however,  the  intensity  of  GFP 
fluorescence with construct 2 is only about 35% of that seen with construct 3. In adult bone marrow 
(of construct 3 mice), 30-40% of the cells are GFP
+ and up to 80% of the Kit
+ population (which 
represents 12-15 % of total cells) express GFP (Table 2). Some Ter-119
+ and Mac-1
+ cells are also 
GFP
+, but they are mostly located in a region of intermediate fluorescence (Mean Fluorescence 
Intensity, MFI, 3.8x10
1, range 2x10
1-2x10
2), whereas Kit 
high cells are mostly located in a region of 
high fluorescence (MFI, 3.2x10
2, range 2x10
2 -3x10
3) (data not shown) The presence of some GFP 
in  Ter-119
+ and  Mac-1
+ cells,  which  are  Kit  low  or  negative,  might  be  due  to  a  low  level  of 
inappropriate expression of the construct; however, the data might also be compatible with a slow 
decay of the high level of GFP synthesized in early Kit
+ progenitors. The fact that GFP expression 
is estinguished in differentiating erythroid and myeloid cells during in vitro culture (see below) 
supports, in our view, the latter possibility.
GFP expression in early hematopoietic progenitors.
 Early multilineage hematopoietic progenitors expressing Kit represent a very minor proportion of 
total hematopoietic cells. To identify different progenitors among GFP
+ cells, we FACS-purified 
GFP
+ and GFP
- cells from fetal livers (E11-12.5) of mice transgenic for constructs 2 and 3, and 
plated  them  for  in  vitro  clonogenic  assays.  Early  progenitors  (CFU-mix,  BFU-E,  etc.)  are 
significantly enriched (> 50%, Table 2) in the GFP
+ fraction (representing ￿ 25% of the total cells) 
in construct 3 line at E11; this proportion somewhat declined at E12.5, when only 4-5% of the total 
cell population was GFP
+ (and Kit
+ cells were only 10-15 % of the total population). This decline 
may represent decreased GFP expression in a more mature cell population with a threshold effect 
on fluorescence detection. A comparable enrichment was detected with construct 2 (not shown).
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In a similar experiment, clonogenic assays were carried out using bone marrow cells from two adult 
construct  3  mice  (line  6)  sorted  into  three  fractions:  a  negative,  an  intermediate  and  a  high 
fluorescence fraction. All the pluripotent progenitors (CFU-mix) were present in the fluorescent 
fractions, with the great majority in the GFP high population (Table 3).
Table 3. GFP
+ progenitors  in bone marrow cells of adult transgenic mice
BFU-E 
%
CFU-GM
%
CFU-mix
%
GFP-High 58 39 73
GFP-Intermediate 36 50 27
GFP-Negative 6 11 0
Average  of  two  experiments.  Percentages  of  erythroid,  myelo-monocytic  and  pluripotent 
progenitors present in different fractions of FACS-sorted bone marrow cells from construct 3 (line 
6) transgenic mice
Similarly,  early  erythroid  precursors  (BFU-E)  were  mostly  highly  fluorescent,  whereas  myelo-
monocytic progenitors (CFU-GM), although highly enriched in the fluorescent population, mainly 
peaked in the GFP intermediate fraction.
Examination  of  developing  colonies  from  adult  bone  marrow  and  unfractionated  fetal  liver 
(construct 3 line) shows that almost all early cell clusters appearing at days 3-5 of the culture are 
intensely fluorescent (Fig. 8A). At later stages of culture (day 9-12), most CFU-mix (97 ± 6 %) and 
BFU-E (78 ± 4%) (Fig 8 B-D) are positive, whereas few CFU-GM (not shown) are fluorescent (11 
± 8 %). Intensely hemoglobinized erythroid cells (Fig. 8E) and mature myelomonocytic cells in 
developing  mixed  colonies  (Fig.  8F)  become  mostly  GFP
-,  indicating  that  the  gene  is 
downregulated according to cell type and stage of maturation. With construct 2, similar results are 
obtained for CFU-mix (84 ± 20 % GFP positivity), but a lower proportion of BFU-E (45 ± 19 %)
and a higher proportion of CFU-GM (28 ± 15 %) express the GFP gene. 
As expected, no fluorescent colonies are obtained with hematopoietic progenitors from construct 1 
lines (not shown).
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Fig. 8. GFP expression in hematopoietic colonies from mice transgenic for construct 3. Cells 
were  observed  in  the  visible  and  fluorescent  light  at  day  4-5  of  culture  (AA’)  and  day  9-12 
(BB’CFU-mix, CC’-EE’ BFU-E; FF’ CFU-mix). Original magnification 100X. Similar results are 
obtained also with construct 2, both using fetal liver and marrow cells. No fluorescence is seen with 
cells from construct 1 mice, and from non-transgenic controls.
Discussion
A molecular understanding of the development and maintenance of stem cells and early progenitors 
will require the elucidation of the transcriptional network controlling the cascade of regulatory 
factors, such as cytokine receptors and trancription factors themselves. The Kit receptor plays a 
unique role, as its expression is critical for the development of several stem and early multipotent 
cell types belonging to unrelated lineages (such as HSC and PGC). The large size and complexity of 
the Kit gene has so far precluded transgenic studies and the delineation of functional elements 
involved in its differential regulation during development. Previous transgenic studies of other large 
hematopoietically-expressed genes, such as CD34, GATA-2 and GATA-3, employed long DNA 
fragments cloned in YAC vectors to reproduce, partly or fully, developmentally regulated 
expression 
46-49. In this work, we used the alternative approach 
50 of first identifying cell type-
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specific DNase I hypersensitive sites of the Kit gene, encompassing potential regulatory regions, 
and then combining them into transgenic constructs driving GFP expression. We thus obtained a 
construct that is correctly expressed throughout the development of hematopoietic and germ cell 
lineages.  Our findings highlight the role of a 3.5 kb fragment (HS2), that is absolutely necessary for 
activity in multipotent hematopoietic progenitors and is required for high level expression in PGCs.
Requirement for correct Kit expression in hematopoiesis.
The results obtained with construct 1 (Figs. 2 and 6, and Table 1) show that the Kit promoter alone 
is sufficient to direct GFP expression to PGCs but is unable to provide activity in hematopoietic 
sites. However the addition of a single element, the HS2 fragment, to generate construct 2 (Figs.2, 5 
and 7, and Table 1), is both sufficient and necessary to drive expression in early haematopoietic 
progenitors.  Further,  the  HS2  fragment  greatly  enhances  the  activity  of  the  promoter  in  PGCs 
(Table 1 and Fig.6). Thus, the HS2 fragment is a key element for expression in both lineages; 
indeed, this site is “open” in the chromatin of all examined Kit expressing cell types (Fig. 1). HS2 
may be required to enhance a weak cell type-specific activity of the promoter, as observed in PGCs. 
However, HS2 itself might also provide cell type-specific activity, for example in hematopoietic 
cells (Table 1). The HS2 fragment contains sequences showing enhancer activity when introduced 
into multipotent ES cells as well as into hematopoietic progenitor cell lines (in preparation); this 
regulatory element might thus be responsive to signals common to several multipotent cell types.
HS3-4-5-6 are open only in hematopoietic cells (Fig.1); these sites are not strictly required for 
expression, but their addition results in a greater proportion of transgenic lines expressing GFP in 
hematopoietic cells (Table 1), a higher activity and a greater percentage of GFP
+ hematopoietic 
colonies (Table 2), relative to construct 2. Further, as expected, GFP expression is appropriately
downregulated in mature erythroid cells and in most differentiated myeloid colonies derived from 
construct 3 transgenics (Fig. 8). In contrast, construct 2 shows a less tight regulatory ability, as it is 
relatively more expressed in myeloid  colonies.  These data suggest that HS3-6 might potentiate 
expression in hematopoietic cells and possibly modulate Kit activity during cell maturation. 
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Kit is a large gene, and we have so far explored the function of only about 20 kb surrounding the 
transcription initiation site. It is thus unlikely that we have identified all the elements required for 
correct  Kit  expression  in  hematopoietic  and  germ  cells.  Indeed,  a  number  of  deletions  or 
rearrangements, mapping from 21 to over 150 kb upstream to the first exon, have been identified in 
mouse 
44,45. These mutations severely  affect Kit expression in melanocytes or in mast-cells.  In 
addition, some of these mutations decrease by 25-40% Kit expression in Kit
+ early hematopoietic 
progenitors,  and  cause  the  disappearance  of  several  mast-cell-specific  chromatin  DNaseI 
hypersensitive sites 
45. In view of the complexity of the Kit locus it is remarkable that a relatively 
short region of DNA as that represented in our constructs 2 and 3 is able to direct proper expression 
in hematopoietic and germ cells.
Recently, Bernex et al.
25 inserted by homologous recombination a lacZ  reporter (l acZ  knock in) 
into the endogeneous mouse Kit gene allowing to evaluate Kit regulation under the control of all Kit 
regulatory sequences. In addition to detecting reporter expression in yolk sac, AGM and fetal liver 
(peaking at E11.5), as we do with our transgenic constructs, they also observed significant activity 
in endothelia, where our constructs are poorly, if at all, expressed. Endothelia and hematopoietic 
cells are thought to derive from a common progenitor, the hemangioblast. Our results therefore 
suggest  that  different  elements  are  required  for  Kit  expression  after  the  divergence  of  the  two 
lineages. Finally it is interesting that only a very low lacZ  activity was detected by Bernex et al.
25
between  E10.5-E13.5  in  PGCs,  a  site  of  abundant  expression  of  Kit  and  of  our  transgenes 
(constructs  2  and  3).  They  suggested  that  this  unexpected  lack  of  activity  was  due  to  the 
replacement of part of the first exon and 200 nucleotides of the first intron by the lacZ cassette, 
which might have deleted or disturbed a PGC regulatory region. Significantly, this is just the 5’ 
portion of the HS2 element, and is immediately upstream to the HS2 site and to a highly conserved 
human-mouse homology sequence, spanning the first ~ 900 nucleotides of the intron.
Correlation between GFP expression and Kit positivity.
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The analysis of GFP
+ cells during development identifies at least two highly expressing cell types: 
hematopoietic  cells  and  PGCs.  All  PGCs  are  expected  to  express  Kit ,  whereas  only  some 
hematopoietic progenitors do 
20,51. Direct analysis of immunoselected PGCs at early (E10.5) and 
more advanced (E11.5) stages shows that almost all cells express GFP (Table 2 and Fig.6), whereas 
no expression in somatic gonadal cells was detectable. This strong correlation indicates that the Kit
promoter  (and  other  regulatory  sequences)  included  in  our  constructs  are  sufficient  for  faithful 
expression in PGCs at these early stages. The proportion of hematopoietic Kit
+ cells expressing 
GFP is also high, though not as much as in PGCs (Table 2), peaking in fetal liver Kit
+ cells (80-85 
%  at  E11.5).  The  reasons  for  the  discrepancy  in  the  expression  levels  between  PGCs  and 
hematopoietic  cells  are  not  yet  known.  One  possibility  is  that  the  construct  is  still  subject, 
particularly  in  hematopoietic  cells,  to  variegation  of  expression  due  to  position  of  integration 
effects,  a  common  observation  in  transgenics.  An  alternative,  though  not  mutually  exclusive 
explanation, is that hematopoietic Kit
+ cells are more heterogeneous than PGCs, and thus their 
ability to express the transgene may depend on the developmental stage and degree of maturation 
levels.
The  latter  hypothesis  is  consistent  with  the  progressive  variation  in  GFP  expression 
observed along development. In sites such as yolk sac and AGM, where hematopoietic cells coexist 
with other Kit expressing cells, GFP expression is detected in the Kit positive fraction already at 
early stages (Table 2). Although in these early sites a large proportion of the Kit positive cells 
express GFP, not all do so (Table 2). In the AGM region, for example, few GFP
+ cells are detected 
intravascularly at E9.5 (Fig. 3) and most GFP
+ cells are likely PGCs (Fig. 3, panel G). At slightly 
later stages (E10.5), a small proportion (5 %) of fetal liver cells express the transgene; these cells 
include early colony forming progenitors (not shown). On the other hand, in fetal liver at E11.5 
most Kit
+ cells express GFP (Fig. 7). Our results in colony assays, indicate that GFP is expressed in 
a high proportion of early progenitors, such as CFU-mix and BFU-Es from fetal liver and adult 
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marrow  (Tables 2 and 3), and in immature cells (Fig. 8), which are known to be Kit
+, whereas, as 
expected, maturation into late erythroblasts or myeloid cells leads to extinction of GFP expression. 
Taken together, our findings are consistent with the possibility that we have identified regulatory 
sequences sufficient for recapitulating several aspects of the normal regulation of Kit expression in 
development and maturation of hematopoietic cells. It remains possible, however, that additional 
regulatory  elements  may  be  required  to  ensure  optimal  levels  of  expression  in  all  Kit
+  cells. 
Experiments are now in progress to evaluate, by transplantation of FACS-sorted cells, if GFP
+ cells 
found in fetal liver or AGM after E11 or in bone marrow  mark not only multipotent erythroid-
myelomonocytic progenitors (Tables 2 and 3), but also HSCs.
Comparison with other early hematopoietic and germ cells transgenes
There are few studies of the transcriptional regulation of genes in stem cells and early progenitors. 
Among the genes studied are those encoding the transcription factors Sox2 (ES and neural stem 
cells) 
13,  Oct-4  (inner  cell  mass,  PGC)
6,9,14,  SCL-Tal  1,  GATA-1  and  GATA-2  (HSC  and/or 
hematopoietic progenitors) 
7,8,10-12,15,16,37 and the surface protein Sca-1 
17,30. 
Among  transgenes  expressed  in  early  hematopoietic  sites,  the  best  characterized  are  those 
dependent on regulatory sequences from the GATA-1 and SCL-Tal-1 genes 
7,10-12,15,16. Although the 
precise identity of the transcription factors regulating these genes during development and in adult 
cells is not yet known 
11,12,15, it is thought that expression in a subset of hematopoietic embryonic-
fetal progenitors requires a GATA factor (possibly GATA-2, expressed in several hematopoietic 
cells) in combination with other not yet identified factors 
11,12,16. Could the expression of Kit/GFP 
transgenes be regulated similarly to GATA-1 and SCL/Tal-1 transgenes? Within the hematopoietic 
system, the expression of Kit constructs 2 and 3 is similar in several respects to that of the SCL-Tal 
1 transgene: expression is detected in the yolk sac, within dorsal aorta and vitelline vessels, in fetal 
liver and in a large proportion of early Kit
+ progenitors (CFU-mix, BFU-E, etc.). Out of about 17 
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GATA motifs detected in the HS2-HS6 fragments, six are clustered within ~400 nt of HS3-HS4 and 
three within ~250 nt of HS5-6, the hematopoietic-specific hypersensitive sites. These motifs might 
represent the basis for expression in hematopoietic regions. 
In addition, Kit was proposed to be a target of the transcription factor SCL-Tal-1 itself. Kit 
expression in hematopoietic cells closely correlates with that of SCL-Tal1, and overexpression of 
SCL-Tal1 may induce Kit transcription in cell lines 
51,52. SCL-Tal1 was suggested to act on Kit
through  DNA  sequences  located  in  the  proximal  Kit  promoter  region,  close  to  HS1
51,52.These 
include a duplicated SCL-Tal-1-binding E-box (5’-CACCTG) 
51, conserved between mouse (at nt -
358 to –342 ) and man and a Sp1-binding motif able to recruit a complex including SCL-Tal1, 
GATA1/2, LMO2 and Ldb1 factors
52. The inactivity of construct 1 in hematopoietic cells (Table 1) 
shows that these sites are insufficient, by themselves, for transgenic Kit-driven GFP expression in 
such cells. However, it is interesting that three E-boxes, with the same motif as that represented in 
the duplicated SCL-Tal1 binding promoter site (out of thirteen detected within the whole HS2-HS6 
region), are clustered immediately downstream to the first exon/first intron junction at positions –3, 
+68 and +65 of the first intron. Two of these sites are perfectly conserved in the human KIT gene, 
where they flank an additional human-specific  E-box. These sites are thus good candidates for 
mediating interactions with the SCL-Tal1 complex bound at the promoter, hence the reported SCL-
Tal1-mediated Kit overexpression
51,52. 
Additional transcription factors are likely responsible for differential expression of Kit and SCL-
Tal1 in other cell types. For example, the latter transgene is highly expressed in vascular endothelia 
(a site of SCL/Tal-1 expression), whereas the Kit transgene is not. On the other hand, the SCL-Tal1 
transgene  is  not  reported  to  be  expressed  in  PGCs
10,15  (which  are  SCL-Tal1  negative,  MDF 
unpublished), whereas the Kit transgene is highly expressed in these cells.
Transgenes  driven  by  the  Oct-4  promoter,  including  an  essential  distal  3.3kb  fragment,  are 
efficiently expressed in the germ line 
6. Oct-4 is a transcription factor first expressed in the early 
embryo and inner cell mass, and then restricted to the germ line. Oct-4 and Kit show very similar 
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expression patterns in the germ line, throughout development. Both genes are highly expressed in 
migratory and proliferating PGCs and downregulated in oocytes entering into meiosis and in mitotic 
G1 arrested prospermatogonia in the fetal gonads 
53, to be reexpressed in growing oocytes and at 
specific later stages of male germ cell differentiation 
53-55
Both Oct-4 
6,9 and Kit transgenes recapitulate correct expression in embryonic germ cells (Fig.3, 
4 and 6, and Table 2). Studies in progress suggest that this correlation extends to postnatal germ 
cells as well (to be reported elsewhere). The similarity of expression of Kit and Oct-4 transgenes in 
the germ line suggests that Kit may be regulated by similar mechanisms as Oct-4, or perhaps by 
Oct-4 itself, in this lineage. 
Conclusions
In  conclusion,  we  have  identified  DNA  regulatory  elements  from  the  Kit  gene,  which  in 
combination are sufficient to recapitulate several aspects of the developmental regulation of Kit in 
two different cell lineages, hematopoietic and germ cells. At least one fragment, the HS2 fragment, 
shows  a  degree  of  hematopoietic  specificity,  as  it  is  absolutely  required  for  expression  in  this 
lineage. The comparison of Kit novel regulatory elements with those of other genes expressed in 
early multipotent progenitors, such as SCL/Tal1
16, Sca-1
29 and Oct-4 
6,9, might allow to further 
dissect transcriptional events underlying early embryonic decisions of these cells.
In addition, the highly GFP
+ mouse lines described here might provide ways to enrich for rare adult 
multipotential  cells.  Indeed,  preliminary  results  (G.  Cossu,  L.C.,  S.O.  et  al.;  A.  Musarò,  N. 
Rosenthal, L.C., S.O. et al., unpublished), indicate that GFP
+ bone marrow progenitors may be 
enriched in cells capable of homing to muscle upon injury and in adult multipotent progenitors 
similar to the meso-angioblast 
56.
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